<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jcm-07-00283-t003" orientation="portrait" position="float" class="table-wrap">
 <object-id pub-id-type="pii" class="object-id">jcm-07-00283-t003_Table 3</object-id>
 <label class="label">Table 3</label>
 <caption class="caption">
  <p class="p">Cytotoxic effect of TB-EO on human cancer cell lines.</p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th"> </th>
    <th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" class="th">IC
     <sub class="sub">50</sub> (µg/mL)
    </th>
   </tr>
   <tr class="tr">
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Compound</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">HeLa-R2</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">LS-174-D3</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">A-549-C5</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">&gt;MRC-5</th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">TB-EO</td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">7.22 ± 1.21</td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">9.30 ± 0.84</td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">8.62 ± 1.41</td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">118.34 ± 0.56</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Cisplatin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">4.24 ± 0.81</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">5.21 ± 0.23</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">5.43 ± 0.34</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">10.08 ± 0.71</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot class="table-wrap-foot">
  <fn class="fn">
   <p class="p">Values presented are means ± standard deviation (SD) of three independent experiments performed in triplicates. HeLa-R2: Human cervical carcinoma cells; LS-174-D3: Colon cancer cells; A-549-C5: Lung adenocarcinoma cells; MRC-5: Normal human fetal lung fibroblast cells; TB-EO: 
    <italic class="italic">T. bovei</italic> essential oil; IC
    <sub class="sub">50</sub>: The concentration of drug that possesses 50% inhibition of cell survival.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
